<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0018609"><a href="http://purl.obolibrary.org/obo/MONDO_0018609">MONDO:0018609</a></h3>
<p><strong>Label:</strong> syndromic hereditary optic neuropathy</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0018105">MONDO:0018105</a> (Wolfram syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0010714">MONDO:0010714</a> (Pelizaeus-Merzbacher disease), <a href="http://purl.obolibrary.org/obo/MONDO_0009263">MONDO:0009263</a> (GAPO syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0018550">MONDO:0018550</a> (spastic paraplegia-optic atrophy-neuropathy and spastic paraplegia-optic atrophy-neuropathy-related disorder), <a href="http://purl.obolibrary.org/obo/MONDO_0009841">MONDO:0009841</a> (PEHO syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0010699">MONDO:0010699</a> (Charcot-Marie-tooth disease X-linked recessive 5),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_99014">Orphanet:99014</a>, <a href="http://purl.obolibrary.org/obo/OMIM_222300">OMIM:222300</a>, <a href="http://purl.obolibrary.org/obo/OMIM_604928">OMIM:604928</a>, <a href="http://purl.obolibrary.org/obo/OMIM_311070">OMIM:311070</a>, <a href="http://purl.obolibrary.org/obo/OMIM_312080">OMIM:312080</a>, <a href="http://www.orpha.net/ORDO/Orphanet_431320">Orphanet:431320</a>, <a href="http://purl.obolibrary.org/obo/OMIM_213900">OMIM:213900</a>, <a href="http://purl.obolibrary.org/obo/OMIM_260565">OMIM:260565</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2067">Orphanet:2067</a>, <a href="http://purl.obolibrary.org/obo/OMIM_230740">OMIM:230740</a>, <a href="http://www.orpha.net/ORDO/Orphanet_2836">Orphanet:2836</a>, <a href="http://www.orpha.net/ORDO/Orphanet_99807">Orphanet:99807</a>, <a href="http://www.orpha.net/ORDO/Orphanet_702">Orphanet:702</a>, <a href="http://purl.obolibrary.org/obo/OMIM_598500">OMIM:598500</a>, <a href="http://www.orpha.net/ORDO/Orphanet_3463">Orphanet:3463</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 46.31%</li>
<li>Thing 46.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 46.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000478">HP:0000478</a> (Abnormality of the eye) 44.65%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system) 40.35%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000598">HP:0000598</a> (Abnormality of the ear) 39.06%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000077">HP:0000077</a> (Abnormality of the kidney) and <a href="http://purl.obolibrary.org/obo/HP_0000648">HP:0000648</a> (Optic atrophy) 37.80%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000648">HP:0000648</a> (Optic atrophy) and <a href="http://purl.obolibrary.org/obo/HP_0010935">HP:0010935</a> (Abnormality of the upper urinary tract) 37.43%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000924">HP:0000924</a> (Abnormality of the skeletal system) 37.25%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000159">HP:0000159</a> (Abnormality of the lip) and <a href="http://purl.obolibrary.org/obo/HP_0000648">HP:0000648</a> (Optic atrophy) 36.27%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) 30.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000119">HP:0000119</a> (Abnormality of the genitourinary system) 23.85%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000152">HP:0000152</a> (Abnormality of head or neck) 23.09%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001507">HP:0001507</a> (Growth abnormality) 20.24%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001626">HP:0001626</a> (Abnormality of the cardiovascular system) 20.11%</li>
</ul>
</body>
</html>
